These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8521721)

  • 21. Identification of Tcf4 residues involved in high-affinity beta-catenin binding.
    Omer CA; Miller PJ; Diehl RE; Kral AM
    Biochem Biophys Res Commun; 1999 Mar; 256(3):584-90. PubMed ID: 10080941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The beta-catenin binding domain of adenomatous polyposis coli is sufficient for tumor suppression.
    Shih IM; Yu J; He TC; Vogelstein B; Kinzler KW
    Cancer Res; 2000 Mar; 60(6):1671-6. PubMed ID: 10749138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The interactions of APC, E-cadherin and beta-catenin in tumour development and progression.
    Ilyas M; Tomlinson IP
    J Pathol; 1997 Jun; 182(2):128-37. PubMed ID: 9274521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular genetic analysis of malignant melanomas for aberrations of the WNT signaling pathway genes CTNNB1, APC, ICAT and BTRC.
    Reifenberger J; Knobbe CB; Wolter M; Blaschke B; Schulte KW; Pietsch T; Ruzicka T; Reifenberger G
    Int J Cancer; 2002 Aug; 100(5):549-56. PubMed ID: 12124804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Three-dimensional structure of the armadillo repeat region of beta-catenin.
    Huber AH; Nelson WJ; Weis WI
    Cell; 1997 Sep; 90(5):871-82. PubMed ID: 9298899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alteration of beta-catenin expression in colonic epithelial cells of familial adenomatous polyposis patients.
    Inomata M; Ochiai A; Akimoto S; Kitano S; Hirohashi S
    Cancer Res; 1996 May; 56(9):2213-7. PubMed ID: 8616874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inactivation of the E-cadherin-mediated cell adhesion system in human cancers.
    Hirohashi S
    Am J Pathol; 1998 Aug; 153(2):333-9. PubMed ID: 9708792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Density-dependent location and interactions of truncated APC and beta-catenin.
    Davies ML; Roberts GT; Spiller DG; Wakeman JA
    Oncogene; 2004 Feb; 23(7):1412-9. PubMed ID: 14647421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. gamma-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin.
    Kolligs FT; Kolligs B; Hajra KM; Hu G; Tani M; Cho KR; Fearon ER
    Genes Dev; 2000 Jun; 14(11):1319-31. PubMed ID: 10837025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A mammalian two-hybrid system for adenomatous polyposis coli-mutated colon cancer therapeutics.
    Wakita K; Tetsu O; McCormick F
    Cancer Res; 2001 Feb; 61(3):854-8. PubMed ID: 11221869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Familial adenomatous polyposis syndrome (FAP): pathogenesis and molecular mechanisms].
    Friedrich A; Kullmann F
    Med Klin (Munich); 2003 Dec; 98(12):776-82. PubMed ID: 14685680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of the APC tumor suppressor protein with catenins.
    Su LK; Vogelstein B; Kinzler KW
    Science; 1993 Dec; 262(5140):1734-7. PubMed ID: 8259519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nuclear accumulation of beta-catenin without an additional somatic mutation in coding region of the APC gene in hepatoblastoma from a familial adenomatous polyposis patient.
    Inukai T; Furuuchi K; Sugita K; Uno K; Ooi A; Sasaki F; Hamada J; Moriuchi T; Nakazawa S
    Oncol Rep; 2004 Jan; 11(1):121-6. PubMed ID: 14654913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction of the DF3/MUC1 breast carcinoma-associated antigen and beta-catenin in cell adhesion.
    Yamamoto M; Bharti A; Li Y; Kufe D
    J Biol Chem; 1997 May; 272(19):12492-4. PubMed ID: 9139698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolation and characterization of a novel human gene, DRCTNNB1A, the expression of which is down-regulated by beta-catenin.
    Kawasoe T; Furukawa Y; Daigo Y; Nishiwaki T; Ishiguro H; Fujita M; Satoh S; Miwa N; Nagasawa Y; Miyoshi Y; Ogawa M; Nakamura Y
    Cancer Res; 2000 Jul; 60(13):3354-8. PubMed ID: 10910037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein.
    Munemitsu S; Albert I; Souza B; Rubinfeld B; Polakis P
    Proc Natl Acad Sci U S A; 1995 Mar; 92(7):3046-50. PubMed ID: 7708772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deletion of an amino-terminal sequence beta-catenin in vivo and promotes hyperphosporylation of the adenomatous polyposis coli tumor suppressor protein.
    Munemitsu S; Albert I; Rubinfeld B; Polakis P
    Mol Cell Biol; 1996 Aug; 16(8):4088-94. PubMed ID: 8754807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carcinogenesis: a balance between beta-catenin and APC.
    Gumbiner BM
    Curr Biol; 1997 Jul; 7(7):R443-6. PubMed ID: 9210368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. APC truncation and increased beta-catenin levels in a human breast cancer cell line.
    Schlosshauer PW; Brown SA; Eisinger K; Yan Q; Guglielminetti ER; Parsons R; Ellenson LH; Kitajewski J
    Carcinogenesis; 2000 Jul; 21(7):1453-6. PubMed ID: 10874025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cadherin and catenin alterations in human cancer.
    Hajra KM; Fearon ER
    Genes Chromosomes Cancer; 2002 Jul; 34(3):255-68. PubMed ID: 12007186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.